Edward Owens manages Vanguard Health Care Fund. Since inception in 1984, his fund has gained 16.8% a year. The fund lost more than 3% this year. These are the first quarter portfolio update of his fund.
Edward Owens buys Ironwood Pharmaceuticals Inc., sells Ims Health Inc. during the 3-months ended 03/31/2010, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 79 stocks with a total value of $18.5 billion. These are the details of the buys and sells.
This is the sector weightings of his portfolio:
These are the top 5 holdings of Edward Owens
Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnson & Johnson has a market cap of $174.75 billion; its shares were traded at around $63.4 with a P/E ratio of 13.6 and P/S ratio of 2.8. The dividend yield of Johnson & Johnson stocks is 3.1%. Johnson & Johnson had an annual average earning growth of 11.1% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 4.5-star.
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. Boston Scientific Corp. has a market cap of $9.99 billion; its shares were traded at around $6.59 with a P/E ratio of 10.7 and P/S ratio of 1.3. Boston Scientific Corp. had an annual average earning growth of 5.4% over the past 10 years.
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. Ironwood Pharmaceuticals Inc. has a market cap of $231.5 million; its shares were traded at around $12.08 .
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin Pharmaceuticals Inc. has a market cap of $2.66 billion; its shares were traded at around $18.54 with and P/S ratio of 3.6.
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Novonordisk A/s has a market cap of $49.39 billion; its shares were traded at around $79.66 with and P/S ratio of 5.1. The dividend yield of Novonordisk A/s stocks is 1.2%.
Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutriti has a market cap of $9.86 billion; its shares were traded at around $48.2 with a P/E ratio of 20.9 and P/S ratio of 3.5. The dividend yield of Mead Johnson Nutriti stocks is 1.9%.
Osi Pharmaceuticals is one of the pharmaceutical research and development organizations, commercializing its skills in drug discovery, preclinical research, and drug development. Osi Pharmaceuticals Inc. has a market cap of $3.34 billion; its shares were traded at around $57.33 with a P/E ratio of 27.2 and P/S ratio of 7.7.
Novartis AG is committed to improving health and well-being through innovative products and services. Novartis Ag has a market cap of $109.72 billion; its shares were traded at around $48.31 with a P/E ratio of 13.1 and P/S ratio of 2.6. The dividend yield of Novartis Ag stocks is 3.4%. Novartis Ag had an annual average earning growth of 14.2% over the past 10 years. GuruFocus rated Novartis Ag the business predictability rank of 5-star.
Edward Owens buys Ironwood Pharmaceuticals Inc., sells Ims Health Inc. during the 3-months ended 03/31/2010, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 79 stocks with a total value of $18.5 billion. These are the details of the buys and sells.
- New Purchases: IRWD,
- Added Positions: BSX, JNJ,
- Reduced Positions: AMLN, MJN, NVO, NVS, OSIP,
- Sold Out:
This is the sector weightings of his portfolio:
| Health Care | 61.4% |
|---|---|
| Consumer Services | 8% |
| Technology | 1.5% |
| Industrials | 0.8% |
| Financials | 0.6% |
| Consumer Goods | 0.1% |
These are the top 5 holdings of Edward Owens
- Merck & Co. Inc. (MRK) - 33,630,248 shares, 6.78% of the total portfolio. Shares reduced by 0.88%
- Forest Laboratories Inc. (FRX) - 29,933,000 shares, 5.07% of the total portfolio. Shares reduced by 0.66%
- Pfizer Inc (PFE) - 43,259,788 shares, 4.01% of the total portfolio.
- McKesson Corp. (MCK) - 11,189,900 shares, 3.97% of the total portfolio.
- Eli Lilly And Company (LLY) - 19,879,900 shares, 3.89% of the total portfolio.
Added: Johnson & Johnson (JNJ, Financial)
Edward Owens added to his holdings in Johnson & Johnson by 47.06%. His purchase prices were between $62.37 and $65.36, with an estimated average price of $63.98. The impact to his portfolio due to this purchase was 0.56%. His holdings were 5,000,000 shares as of 03/31/2010.Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnson & Johnson has a market cap of $174.75 billion; its shares were traded at around $63.4 with a P/E ratio of 13.6 and P/S ratio of 2.8. The dividend yield of Johnson & Johnson stocks is 3.1%. Johnson & Johnson had an annual average earning growth of 11.1% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 4.5-star.
Added: Boston Scientific Corp. (BSX, Financial)
Edward Owens added to his holdings in Boston Scientific Corp. by 119.57%. His purchase prices were between $6.8 and $9.62, with an estimated average price of $8.14. The impact to his portfolio due to this purchase was 0.43%. His holdings were 20,200,000 shares as of 03/31/2010.Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. Boston Scientific Corp. has a market cap of $9.99 billion; its shares were traded at around $6.59 with a P/E ratio of 10.7 and P/S ratio of 1.3. Boston Scientific Corp. had an annual average earning growth of 5.4% over the past 10 years.
New Purchase: Ironwood Pharmaceuticals Inc. (IRWD, Financial)
Edward Owens initiated holdings in Ironwood Pharmaceuticals Inc.. His purchase prices were between $11.5 and $14.63, with an estimated average price of $13.03. The impact to his portfolio due to this purchase was 0.15%. His holdings were 2,000,000 shares as of 03/31/2010.Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. Ironwood Pharmaceuticals Inc. has a market cap of $231.5 million; its shares were traded at around $12.08 .
Reduced: Amylin Pharmaceuticals Inc. (AMLN, Financial)
Edward Owens reduced to his holdings in Amylin Pharmaceuticals Inc. by 11.38%. His sale prices were between $22.67 and $22.95, with an estimated average price of $22.81. The impact to his portfolio due to this sale was -0.02%. Edward Owens still held 1,557,200 shares as of 03/31/2010.Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin Pharmaceuticals Inc. has a market cap of $2.66 billion; its shares were traded at around $18.54 with and P/S ratio of 3.6.
Reduced: Novonordisk A/s (NVO, Financial)
Edward Owens reduced to his holdings in Novonordisk A/s by 12.5%. His sale prices were between $63.85 and $79.13, with an estimated average price of $71.13. The impact to his portfolio due to this sale was -0.04%. Edward Owens still held 700,000 shares as of 03/31/2010.Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Novonordisk A/s has a market cap of $49.39 billion; its shares were traded at around $79.66 with and P/S ratio of 5.1. The dividend yield of Novonordisk A/s stocks is 1.2%.
Reduced: Mead Johnson Nutriti (MJN, Financial)
Edward Owens reduced to his holdings in Mead Johnson Nutriti by 21.12%. His sale prices were between $43.62 and $52.35, with an estimated average price of $47.55. The impact to his portfolio due to this sale was -0.12%. Edward Owens still held 2,068,137 shares as of 03/31/2010.Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutriti has a market cap of $9.86 billion; its shares were traded at around $48.2 with a P/E ratio of 20.9 and P/S ratio of 3.5. The dividend yield of Mead Johnson Nutriti stocks is 1.9%.
Reduced: Osi Pharmaceuticals Inc. (OSIP, Financial)
Edward Owens reduced to his holdings in Osi Pharmaceuticals Inc. by 13.02%. His sale prices were between $30.92 and $60.06, with an estimated average price of $42.79. The impact to his portfolio due to this sale was -0.14%. Edward Owens still held 3,340,873 shares as of 03/31/2010.Osi Pharmaceuticals is one of the pharmaceutical research and development organizations, commercializing its skills in drug discovery, preclinical research, and drug development. Osi Pharmaceuticals Inc. has a market cap of $3.34 billion; its shares were traded at around $57.33 with a P/E ratio of 27.2 and P/S ratio of 7.7.
Reduced: Novartis Ag (NVS, Financial)
Edward Owens reduced to his holdings in Novartis Ag by 27.16%. His sale prices were between $51.91 and $55.52, with an estimated average price of $54.06. The impact to his portfolio due to this sale was -0.49%. Edward Owens still held 6,169,880 shares as of 03/31/2010.Novartis AG is committed to improving health and well-being through innovative products and services. Novartis Ag has a market cap of $109.72 billion; its shares were traded at around $48.31 with a P/E ratio of 13.1 and P/S ratio of 2.6. The dividend yield of Novartis Ag stocks is 3.4%. Novartis Ag had an annual average earning growth of 14.2% over the past 10 years. GuruFocus rated Novartis Ag the business predictability rank of 5-star.
